{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:32:40Z","timestamp":1792096360293,"version":"4.4.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jaip.2023.09.031","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T20:45:04Z","timestamp":1696538704000},"page":"3615-3623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Drug Allergy in Women"],"prefix":"10.1016","volume":"11","author":[{"given":"Erika Yue","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Copaescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Trubiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna R.","family":"Wolfson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1691-4232","authenticated-orcid":false,"given":"Allison","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2023.09.031_bib1","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/all.12881","article-title":"Drug allergies documented in electronic health records of a large healthcare system","volume":"71","author":"Zhou","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.09.031_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jaip.2018.06.010","article-title":"Drug-induced anaphylaxis documented in electronic health records","volume":"7","author":"Dhopeshwarkar","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.09.031_bib3","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s11096-017-0535-2","article-title":"Drug-induced anaphylaxis in China: a 10 year retrospective analysis of the Beijing Pharmacovigilance Database","volume":"40","author":"Zhao","year":"2018","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.jaip.2023.09.031_bib4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.alit.2023.03.006","article-title":"Analysis of drug-induced anaphylaxis cases using the Japanese Adverse Drug Event Report (JADER) database \u2013 secondary publication","volume":"72","author":"Sugizaki","year":"2023","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2023.09.031_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00132586-199902000-00059","article-title":"Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies","volume":"43","author":"Lazarou","year":"1999","journal-title":"Surv Anesthesiol"},{"key":"10.1016\/j.jaip.2023.09.031_bib6","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1016\/j.jaip.2022.08.020","article-title":"Allergy electronic health record documentation: a 2022 work group report of the AAAAI Adverse Reactions to Drugs, Biologicals, and Latex Committee","volume":"10","author":"Guyer","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.09.031_bib7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.anai.2017.07.009","article-title":"Frequency of self-reported drug allergy","volume":"119","author":"Sousa-Pinto","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib8","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review of PubMed\/MEDLINE case reports from 1980 to 2020","volume":"9","author":"Wang","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.jaip.2023.09.031_bib9","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.jaip.2023.02.035","article-title":"Drug reaction with eosinophilia and systemic symptoms: a systematic review","volume":"11","author":"Awad","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.09.031_bib10","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1365-2222.2004.02070.x","article-title":"Self-reported drug allergy in a general adult Portuguese population","volume":"34","author":"Gomes","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2023.09.031_bib11","first-page":"45","article-title":"The epidemiology of drug allergy-related consultations in Spanish allergology services: Alergol\u00f3gica-2005","volume":"19","author":"Gamboa","year":"2009","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib12","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1590\/S1807-59322011000600004","article-title":"Anaphylaxis in Latin America: a report of the online Latin American survey on anaphylaxis (OLASA)","volume":"66","author":"Sol\u00e9","year":"2011","journal-title":"Clinics"},{"key":"10.1016\/j.jaip.2023.09.031_bib13","first-page":"2440","article-title":"Drug-induced anaphylaxis survey in Portuguese allergy departments","author":"Faria","year":"2014","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.7812\/TPP\/09-105","article-title":"A\u00a0practical drug allergy update: what you need to know about drug allergies but did not learn in medical school","volume":"13","author":"Macy","year":"2009","journal-title":"Perm J"},{"key":"10.1016\/j.jaip.2023.09.031_bib15","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1365-2125.2010.03774.x","article-title":"Epidemiology and risk factors for drug allergy: epidemiology and risk factors for drug allergy","volume":"71","author":"Thong","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2023.09.031_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.aller.2018.05.006","article-title":"Prevalence of self-reported drug hypersensitivity reactions among Lithuanian children and adults","volume":"47","author":"Kvedariene","year":"2019","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2023.09.031_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.2117","article-title":"Factors associated with penicillin allergy labels in electronic health records of children in 2 large US pediatric primary care networks","volume":"5","author":"Taylor","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2023.09.031_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.aller.2010.02.009","article-title":"Immediate-type drug hypersensitivity and associated factors in a general population","volume":"39","author":"Kurt","year":"2011","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2023.09.031_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.555666","article-title":"Drug allergy profile from a national drug allergy registry","volume":"11","author":"Al-Ahmad","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaip.2023.09.031_bib20","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaci.2014.08.018","article-title":"Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations","volume":"134","author":"Jerschow","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.anai.2017.07.014","article-title":"Risk factors for severe anaphylaxis in the United States","volume":"119","author":"Motosue","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib22","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jaci.2014.05.018","article-title":"Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals","volume":"134","author":"Clark","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib23","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jaci.2014.10.021","article-title":"Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012","volume":"135","author":"Turner","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib24","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jaci.2013.10.029","article-title":"Case fatality and population mortality associated with anaphylaxis in the United States","volume":"133","author":"Ma","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib25","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/all.13380","article-title":"Factors increasing the risk for a severe reaction in anaphylaxis: an analysis of data from the European Anaphylaxis Registry","volume":"73","author":"Worm","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.09.031_bib26","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1001\/jama.1986.03380240052027","article-title":"Drug-induced cutaneous reactions: a report From the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982","volume":"256","author":"Bigby","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2023.09.031_bib27","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1046\/j.1365-2125.1999.00096.x","article-title":"Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions: spontaneous reporting of cutaneous drug reactions","volume":"48","author":"Naldi","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2023.09.031_bib28","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jamadermatol.2022.6378","article-title":"Worldwide prevalence of antibiotic-associated Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"159","author":"Lee","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2023.09.031_bib29","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1172\/JCI93349","article-title":"Randomized, controlled trial of TNF-\u03b1 antagonist in CTL-mediated severe cutaneous adverse reactions","volume":"128","author":"Wang","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2023.09.031_bib30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/jamadermatol.2021.5390","article-title":"Clinical characteristics, disease course, and outcomes of patients with acute generalized exanthematous pustulosis in the US","volume":"158","author":"Creadore","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2023.09.031_bib31","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0091-6749(05)80222-2","article-title":"Tryptase, a mediator of human mast cells","volume":"86","author":"Schwartz","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.anai.2016.10.003","article-title":"Skin testing and drug challenge outcomes in antibiotic-allergic patients with immediate-type hypersensitivity","volume":"118","author":"Mawhirt","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib33","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jaip.2022.11.001","article-title":"Patient characteristics associated with reactions to Mrgprx2-activating drugs in an electronic health record\u2013linked biobank","volume":"11","author":"Foer","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.09.031_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat1479","article-title":"An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxis","volume":"11","author":"J\u00f6nsson","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaip.2023.09.031_bib35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tox.2005.07.023","article-title":"Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity","volume":"216","author":"Szebeni","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.jaip.2023.09.031_bib36","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000451069","article-title":"Complement activation-related pseudo-allergy: a fresh look at hypersensitivity reactions to intravenous iron","volume":"45","author":"Macdougall","year":"2017","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jaip.2023.09.031_bib37","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3324\/haematol.2014.111492","article-title":"Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management","volume":"99","author":"Rampton","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jaip.2023.09.031_bib38","article-title":"Anaphylaxis to iodinated contrast media: clinical characteristics related with development of anaphylactic shock","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2023.09.031_bib39","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1001\/jama.2015.15572","article-title":"Comparative risk of anaphylactic reactions associated with intravenous iron products","volume":"314","author":"Wang","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2023.09.031_bib40","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.4488","article-title":"Analysis of adverse events and intravenous iron infusion formulations in adults\u00a0with and without prior infusion reactions","volume":"5","author":"Arastu","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2023.09.031_bib41","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/M21-4009","article-title":"Risks for anaphylaxis with intravenous iron formulations: a retrospective cohort study","volume":"175","author":"Dave","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2023.09.031_bib42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jaci.2022.12.005","article-title":"Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions","volume":"151","author":"Gibson","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"suppl 1","key":"10.1016\/j.jaip.2023.09.031_bib43","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/00126334-200309011-00005","article-title":"A\u00a0comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients","volume":"34","author":"Stern","year":"2003","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jaip.2023.09.031_bib44","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1086\/317536","article-title":"Sex differences in nevirapine rash","volume":"32","author":"Bersoff-Matcha","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2023.09.031_bib45","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/QAD.0b013e32834779df","article-title":"Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent","volume":"25","author":"Yuan","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2023.09.031_bib46","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/cpt.2343","article-title":"Immunopharmacogenomics: mechanisms of HLA-associated drug reactions","volume":"110","author":"Deshpande","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2023.09.031_bib47","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/cts.13291","article-title":"Associations of HLA genetic variants with carbamazepine-induced cutaneous adverse drug reactions: an updated meta-analysis","volume":"15","author":"Biswas","year":"2022","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jaip.2023.09.031_bib48","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/cts.13062","article-title":"HLA-associated adverse drug reactions - scoping review","volume":"14","author":"Jeiziner","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jaip.2023.09.031_bib49","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1073\/pnas.1716146115","article-title":"Sex bias in MHC I-associated shaping of the adaptive immune system","volume":"115","author":"Schneider-Hohendorf","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2023.09.031_bib50","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/jamadermatol.2022.0484","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis\u2014coordinating research priorities to move the field forward","volume":"158","author":"Phillips","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2023.09.031_bib51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000448217","article-title":"HLA and delayed drug-induced hypersensitivity","volume":"170","author":"Sousa-Pinto","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib52","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2217\/pgs.15.21","article-title":"Genetic markers associated with cutaneous adverse drug reactions to allopurinol: a systematic review","volume":"16","author":"Jarjour","year":"2015","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jaip.2023.09.031_bib53","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","article-title":"A\u00a0European study of HLA-B in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs","volume":"18","author":"Lonjou","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaip.2023.09.031_bib54","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/bjd.12389","article-title":"HLA-B\u221758:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome\/toxic epidermal necrolysis in a Portuguese population","volume":"169","author":"Gon\u00e7alo","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2023.09.031_bib55","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/jamainternmed.2015.3536","article-title":"Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan","volume":"175","author":"Yang","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaip.2023.09.031_bib56","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7812\/TPP\/16-080","article-title":"Morbidity in pregnant women associated with unverified penicillin allergies, antibiotic use, and group B Streptococcus infections","volume":"21","author":"Desai","year":"2017","journal-title":"Perm J"},{"key":"10.1016\/j.jaip.2023.09.031_bib57","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/aas.13730","article-title":"Effect of penicillin allergy on prophylactic antibiotic administration in the parturient undergoing cesarean delivery","volume":"65","author":"Lange","year":"2021","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jaip.2023.09.031_bib58","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12887-021-02797-8","article-title":"Outcomes in reported penicillin allergic mothers and neonates requiring group B streptococcal prophylaxis: a retrospective observational cohort study","volume":"21","author":"Kirven","year":"2021","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.jaip.2023.09.031_bib59","article-title":"Prevention of group B streptococcal early-onset disease in newborns","volume":"144","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2023.09.031_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13608","article-title":"Perinatal outcome and long-term infectious hospitalizations of offspring born to women with known drug allergy","volume":"88","author":"Mahamid","year":"2022","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib61","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1081-1206(10)60007-5","article-title":"Penicillin skin testing in pregnant women with a history of penicillin allergy and group B streptococcus colonization","volume":"97","author":"Macy","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib62","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaip.2020.10.063","article-title":"Penicillin allergy assessment in pregnancy: safety and impact on antibiotic use","volume":"9","author":"Wolfson","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.09.031_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2022.100674","article-title":"Outpatient penicillin allergy evaluation during pregnancy and associated clinical outcomes","volume":"4","author":"Kwah","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.jaip.2023.09.031_bib64","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.anai.2020.08.012","article-title":"Skin testing and oral amoxicillin challenge in the outpatient allergy and clinical immunology clinic in pregnant women with penicillin allergy","volume":"125","author":"Kuder","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib65","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/AOG.0000000000004213","article-title":"Outpatient penicillin allergy testing in pregnant women who report an allergy","volume":"137","author":"Desravines","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaip.2023.09.031_bib66","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2022-001859","article-title":"Improving routine prenatal penicillin allergy testing for reported penicillin allergy","volume":"11","author":"Gill","year":"2022","journal-title":"BMJ Open Qual"},{"key":"10.1016\/j.jaip.2023.09.031_bib67","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.jaip.2022.03.025","article-title":"Safety of direct oral challenge to amoxicillin in pregnant patients at a Canadian tertiary hospital","volume":"10","author":"Mak","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.09.031_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/a-1877-9970","article-title":"Survey of obstetric providers to assess the knowledge and management of a reported penicillin allergy in pregnant women","volume":"40","author":"Cate","year":"2023","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jaip.2023.09.031_bib69","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1016\/j.jaip.2020.08.018","article-title":"Patient characteristics and concerns about drug allergy: a report from the United States Drug Allergy Registry","volume":"8","author":"Blumenthal","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.09.031_bib70","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.jaip.2021.01.047","article-title":"Prevalence of antibiotic allergy labels in a tertiary referral center in Belgium","volume":"9","author":"Gilissen","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.09.031_bib71","first-page":"124","article-title":"Prevalence of antibiotic allergy labels and their consequences in people presenting to a teaching hospital emergency department; a retrospective chart review","volume":"39","year":"2021","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib72","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jaip.2021.10.043","article-title":"Population-based incidence of new ampicillin, cephalexin, cefaclor, and sulfonamide antibiotic \u201callergies\u201d in exposed individuals with and without preexisting ampicillin, cephalexin, or cefaclor \u201callergies.\u201d","volume":"10","author":"Macy","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.09.031_bib73","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/cid\/cix773","article-title":"Antibiotic expenditures by medication, class, and healthcare setting in the United States, 2010-2015","volume":"66","author":"Suda","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2023.09.031_bib74","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2023.09.031_bib75","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.urology.2017.08.070","article-title":"Impact of allergy and resistance on antibiotic selection for recurrent urinary tract infections in older women","volume":"113","author":"Malik","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.jaip.2023.09.031_bib76","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1016\/j.jaip.2020.08.033","article-title":"Tackling the patient with multiple drug \u201callergies\u201d: multiple drug intolerance syndrome","volume":"8","author":"Guyer","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.09.031_bib77","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.anai.2011.11.006","article-title":"Multiple drug intolerance syndrome: prevalence, clinical characteristics, and management","volume":"108","author":"Macy","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib78","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1111\/all.13440","article-title":"Multiple drug intolerance syndrome and multiple drug allergy syndrome: epidemiology and associations with anxiety and depression","volume":"73","author":"Blumenthal","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.09.031_bib79","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s40264-014-0236-x","article-title":"Multiple drug intolerance syndrome: a large-scale retrospective study","volume":"37","author":"Omer","year":"2014","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2023.09.031_bib80","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12190","article-title":"Characterization, epidemiology and risk factors of multiple drug allergy syndrome and multiple drug intolerance syndrome: a systematic review","volume":"12","author":"Jagpal","year":"2022","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2023.09.031_bib81","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1081-1206(10)60637-0","article-title":"Multiple-drug intolerance syndrome: clinical findings and usefulness of challenge tests","volume":"99","author":"Schiavino","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib82","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update","volume":"150","author":"Khan","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib83","first-page":"147","article-title":"Gender differences in the utilization of health care services","volume":"49","author":"Bertakis","year":"2000","journal-title":"J\u00a0Fam Pract"},{"key":"10.1016\/j.jaip.2023.09.031_bib84","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3389\/fimmu.2018.02279","article-title":"Sex hormones in acquired immunity and autoimmune disease","volume":"9","author":"Moulton","year":"2018","journal-title":"Front Immunol"},{"issue":"suppl 2","key":"10.1016\/j.jaip.2023.09.031_bib85","first-page":"21","article-title":"Epidemiology, healthcare, resources, use and clinical features of different types of urticaria","volume":"19","author":"Ferrer","year":"2009","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib86","article-title":"Sex hormone influence on female-biased autoimmune diseases hints at puberty as an important factor in pathogenesis","volume":"11","author":"Yang","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2023.09.031_bib87","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaut.2009.03.006","article-title":"Autoimmunity and Klinefelter\u2019s syndrome: when men have two X chromosomes","volume":"33","author":"Sawalha","year":"2009","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaip.2023.09.031_bib88","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13223-019-0372-z","article-title":"Stress, pseudoallergens, autoimmunity, infection and inflammation in chronic spontaneous urticaria","volume":"15","author":"Bansal","year":"2019","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib89","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.jaci.2014.02.036","article-title":"The diagnosis and management of acute and chronic urticaria: 2014 update","volume":"133","author":"Bernstein","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib90","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1574886315666201002153354","article-title":"Factors associated with self-reported drug allergies in a large chronic spontaneous urticaria cohort","volume":"16","author":"Rauscher","year":"2021","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.jaip.2023.09.031_bib92","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11882-017-0686-1","article-title":"Mechanisms driving gender differences in asthma","volume":"17","author":"Fuseini","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2023.09.031_bib93","doi-asserted-by":"crossref","first-page":"60","DOI":"10.23822\/EurAnnACI.1764-1489.225","article-title":"Hypersensitivity reactions to iodinate contrast media in Italy: a retrospective study. Characteristics of patients and risk factors","volume":"54","author":"Voltolini","year":"2022","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib94","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaip.2014.11.011","article-title":"Comprehensive allergy evaluation is useful in the subsequent care of patients with drug hypersensitivity reactions during anesthesia","volume":"3","author":"Guyer","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.09.031_bib95","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1111\/all.15304","article-title":"Idiopathic mast cell activation syndrome is more often suspected than diagnosed\u2014A prospective real-life study","volume":"77","author":"Buttgereit","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2023.09.031_bib96","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/ACI.0b013e328355b7cb","article-title":"Drug allergy in mast cell disease","volume":"12","author":"Brockow","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2023.09.031_bib97","doi-asserted-by":"crossref","first-page":"e710","DOI":"10.1016\/S2665-9913(22)00198-9","article-title":"Investigating sex differences in T regulatory cells from cisgender and transgender healthy individuals and patients with autoimmune inflammatory disease: a cross-sectional study","volume":"4","author":"Robinson","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaip.2023.09.031_bib98","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1002\/art.23701","article-title":"Klinefelter\u2019s syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome","volume":"58","author":"Scofield","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaip.2023.09.031_bib99","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3390\/ijms22031114","article-title":"Escape from X chromosome inactivation and the female predominance in autoimmune diseases","volume":"22","author":"Youness","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2023.09.031_bib100","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jaip.2020.09.010","article-title":"Safety, Efficacy, and effectiveness of delabeling in patients with multiple drug allergy labels","volume":"9","author":"Vethody","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2023.09.031_bib101","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/jwh.2021.0103","article-title":"Sex differences in use of a clinical complexity measure to predict primary care utilization","volume":"31","author":"Haskell","year":"2022","journal-title":"J\u00a0Womens Health"},{"key":"10.1016\/j.jaip.2023.09.031_bib102","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.3390\/ijerph17113926","article-title":"Gender differences in medication use: a drug utilization study based on real world data","volume":"17","author":"Orlando","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jaip.2023.09.031_bib103","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/jwh.2007.0422","article-title":"Sex differences in treatment patterns of six chronic diseases: an analysis from\u00a0the German statutory health insurance","volume":"17","author":"Stock","year":"2008","journal-title":"J\u00a0Womens Health"},{"key":"10.1016\/j.jaip.2023.09.031_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0259069","article-title":"Exploring gender differences in knowledge and practices related to antibiotic use in Southeast Asia: a scoping review","volume":"16","author":"Pham-Duc","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2023.09.031_bib105","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1089\/jwh.2009.1448","article-title":"Patient gender differences in the prediction of medical expenditures","volume":"19","author":"Bertakis","year":"2010","journal-title":"J\u00a0Womens Health"},{"key":"10.1016\/j.jaip.2023.09.031_bib106","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1017\/S0033291707002012","article-title":"Co-morbid major depression and generalized anxiety disorders in the National Comorbidity Survey follow-up","volume":"38","author":"Kessler","year":"2008","journal-title":"Psychol Med"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823010632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219823010632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T01:24:56Z","timestamp":1716427496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219823010632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":105,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2213219823010632"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2023.09.031","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug Allergy in Women","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2023.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}